Fosfomycin
Brand names: Monuril
Fosfomycin is a broad-spectrum bactericidal antibiotic given as a single oral sachet of fosfomycin trometamol, used for uncomplicated lower urinary tract infection in women, including some caused by multidrug-resistant organisms such as ESBL-producing coliforms.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It irreversibly inhibits MurA (UDP-N-acetylglucosamine enolpyruvyl transferase), blocking an early step in bacterial cell-wall peptidoglycan synthesis and so killing the organism.
Prescribing in practice
- Confirm the diagnosis is uncomplicated lower UTI before use; efficacy depends on adequate urinary concentrations, so it is not appropriate for pyelonephritis or other upper/complicated urinary tract infection unless specifically advised.
- Take on an empty stomach, ideally at bedtime after emptying the bladder, dissolved in water; for treatment courses a second sachet may be advised after an interval per the SPC.
- Resistance and reduced activity occur with some organisms, so prescribe according to local susceptibility data and resistance patterns.
Monitoring
Routine laboratory monitoring is not required; review clinically and arrange urine culture if symptoms persist or recur.
Counselling the patient
- Dissolve the whole sachet in a glass of cold water and drink immediately on an empty stomach, preferably before bed.
- Return if symptoms do not settle within a few days or worsen.
Evidence & guidelines
Single-dose fosfomycin trometamol is recommended in NICE and UK antimicrobial guidance as an option for uncomplicated UTI, particularly where resistance limits other agents.
Reference: NICE NG109 (UTI in adults); PHE Antimicrobial Prescribing Guidelines; EUCAST resistance data; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Tumor Lysis Syndrome Risk (Cairo-Bishop) · Oncological Emergency
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification